SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-056099
Filing Date
2021-04-28
Accepted
2021-04-28 09:12:44
Documents
3
Period of Report
2021-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2114435d1_6k.htm 6-K 9707
2 EXHIBIT 99.1 tm2114435d1_ex99-1.htm EX-99.1 15668
3 GRAPHIC tm2114435d1_ex99-1img01.jpg GRAPHIC 3223
  Complete submission text file 0001104659-21-056099.txt   30958
Mailing Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Filer) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39308 | Film No.: 21861662
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences